ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Global Management Forum 2019

Takeda focuses on 'high priority' Asia after huge bet on Shire

Drugmaker taking break from acquisitions but wants partners, CEO Weber says

Takeda Pharmaceutical President and CEO Christophe Weber speaks to the Nikkei Asian Review on the sidelines of the Nikkei Global Management Forum on Oct. 29 in Tokyo. (Photo by Shihoko Nakaoka)

TOKYO -- Takeda Pharmaceutical has high hopes for China, India and Southeast Asia, as Japan's largest drugmaker looks to further extend its international reach, CEO Christophe Weber said in an interview on Tuesday.

"Asia is a high priority for us," Weber said on the sidelines of the Nikkei Global Management Forum. "With 3 billion people, health care demand is strong and countries like China and India are big potential markets."

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more